BACKGROUND Methicillin resistance staphylococcus aureus (MRSA) is one of the most serious contemporary challenges to the treatment of hospital acquired infections, because of its global spread prevalence. We aimed to screen the prevalence and assess the antibiotic susceptibility pattern of MRSA from clinical specimens in a tertiary care hospital.
well as a community associated (CA-MRSA) infection causing wide range of diseases. 7 MRSA infection is a serious concern, because of its resistance to commonly used antibiotics. Many of the MRSA isolates are becoming multidrug resistant and are showing susceptibility only to glycopeptides such as vancomycin. At present, they are showing low level resistance even to vancomycin. 2 Control of MRSA isolates in hospitals and communities is a major challenge as the resistance phenotype varies according to the environmental conditions. 6 Therefore early detection, knowledge of local prevalence and formulation of effective antibiotic policy in a tertiary care hospital is of paramount importance. The present study has been carried out to know the prevalence and antibiogram of staphylococcus aureus with special reference to MRSA in a tertiary care hospital.
MATERIALS AND METHODS
Our study included 210 non-duplicate staphylococcal isolates from various clinical samples of pus, sputum, blood, urine and body fluids from patients of both admitted cases (IPD) and Outpatient Departments (OPD) from February 2013 to December 2015. The specimens were cultured on blood agar and MacConkey agar plates and incubated aerobically at 37 o c for 48 hours. Identification of the isolates was carried out by standard laboratory operating procedures (Gram staining, catalase test, slide and tube Coagulase test and growth on Mannitol salt agar). 8 Antibiotic sensitivity testing of all the strains was performed by modified Kirby-Bauer disc diffusion method as per CLSI guidelines for the following antibioticspenicillin (10 units), Gentamycin (10 µg), Erythromycin (15 µg), ciprofloxacin (5 µg), Linezolid (30 µg), Amikacin (30 µg), Ampicillin (10) cotrimoxazole (35), Cefotaxime (30 µg), Vancomycin (30 µg) and cefoxitin (30 µg) obtained from Hi-Media, Mumbai.
Antibiogram was done on Muller-Hinton agar, and were interpreted after 24 hrs. of aerobic incubation at 37 o C. Testing for Methicillin resistance was performed using cefoxitin (30 µg) disc diffusion method as per CLSI recommendations. The zone diameters were measured around each antibiotic disc and interpreted as per CLSI guidelines using S. aureus ATCC 25923 as a standard control strain. The isolates were considered as Methicillin resistant if the zone of inhibition was ≤ 21 mm. The data was recorded and statistical analysis was done using (SPSS 17) to calculate P -value.
RESULTS
Out of 210 staphylococcal isolates, 165 (78.57%) were staphylococcus aureus and 45 (21.43%) were coagulase negative staphylococci. Among the 165 staphylococcus aureus isolates, 53 (32.12%) were MRSA. Highest numbers of isolates were from pus and wound swab and least in blood and body fluids. Distribution of Methicillin Sensitive Staphylococcus aureus (MSSA) and MRSA among the clinical samples is given in Table 1 and isolates from Outpatient Departments (OPD) and Inpatient Departments (IPD) in Table 2 . (6) -
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DISCUSSION
The significance of MRSA has been recognised relatively late in India, and it emerged as a problem in last decades of 20 th century. Strains of MRSA are also showing resistance to several other antibiotics. 9 The major reservoirs of MRSA in hospital are infected or carrier patients and transient carriage of them by healthcare workers. 10 In this study, the prevalence of MRSA was 32.12%. The prevalence of MRSA varies from 0.4% to 48.4% among different countries. 11 In India MRSA prevalence varies in different areas, which might be because of several factors like efficacy of infection control policies, healthcare facilities and antibiotic usage that vary from one hospital to other. 12 Maximum samples of MRSA were isolated from pus followed by urine. In comparison to inpatient and outpatient departments, MRSA were 69.82% (37) and 30.18% (16) respectively.
The resistance pattern of IPD -MRSA were higher when compared to those of OPD -MRSA, which may be due to chronic carrier stage among healthcare workers, greater resistance of the strain, prolonged hospital stay, emergency surgery, admission in ICU or Burns Unit and receipt of antibiotics before coming to the hospital. 13 There is no significant difference in infection of males and females with staphylococcus aureus, whereas resistant types (MRSA) were slightly higher in females. This may be due to different factors such as microbial community in patient bodies, method and distribution of specimen collection during the period of the study. 14 MRSA has become one of the established hospital acquired pathogen and its epidemiology is gradually changing and the association of multidrug resistance with MRSA has added to the problem. β-Lacto antibiotics were not found to be effective against MRSA.
Very high resistance to quinolones (Ciprofloxacin 84.9%) was also found, which correlates with other studies. 15 MRSA strains were to be more resistant to other antibiotics than MSSA strains. Significant difference (p < 0.005) was observed in case of penicillin, erythromycin, ciprofloxacin, Ampicillin and Gentamycin. However, the difference observed in case of Amikacin and Cotrimoxazole was insignificant (P > 0.05). Our study shows a marked difference between sensitivity pattern of MRSA and MSSA, which also correlates with Vidhani S et al, 16 Majumder D et al 17 and Shilpa Arora et al. 12 Linezolid has good activity against staphylococci including MRSA. Thus, it is a promising therapeutic option. 18 In the present study all the isolates (MRSA and MSSA) were sensitive to vancomycin, which is in accordance with other studies 2, 6, 19 ; however, regular monitoring of vancomycin sensitivity and routine testing of other new glycopeptides should be carried out to prevent the emergence of resistance.
CONCLUSION
Vancomycin remains the first choice of treatment for MRSA. To preserve its value, use of vancomycin should be limited for the treatment of resistant and life-threatening infections. Regular surveillance of hospital associated infections including MRSA and their local resistance profiles may be helpful for formulation of definite antibiotic policy and for effective infection control practices.
